OBJECTIVE: To investigate the peripheral blood components, neutrophil/lymphocyte ratio (NLR) andplatelet/lymphocyte ratios (PLR) in cervical cytological abnormalities. STUDY DESIGN: We retrospectively analyzed 185 cases with abnormal and 303 cases with normal cervicovaginal smears (CVS) with blood count profile, from a total number of 9286 patients. RESULTS: Abnormal CVS results consisted of 137 (72%) ASC-US, 16 (8%) ASC-H, 19 (10%) L-SIL, 4(2%) H-SIL and 9 (4%) AGUS. NLR and PLR of abnormal CVS group were higher than control group(p<0.001). The lymphocyte count was significantly lower in abnormal CVS cases (p<0.001). The number of patients with neutrophilia (neutrophils >=70% of the total leukocytes) was similar among two groups(p>0.05).CONCLUSION: Neutrophilia is not observed in cervical preinvasive lesions whereas it is common in cervical cancer. In this study, absence of increased neutrophil counts and presence of lymphopenia in patients with abnormal cervical cytology, may indicate an early measure in cervical pathologies.
Fernandes PC, Garcia CB, Micheli DC, Cunha FQ, Murta EFC. Circulating neutrophils may play a role in the host response in cervical cancer. Int J Gynecol Cancer 2007; 17:1068-74.
Kose M, Celik F, Kose SK, Arioz DT, Yilmazer M. Could the platelet-to-lymphocyte ratio be a novel marker for pre- dicting invasiveness of cervical pathologies? Asian Pac J Cancer Prev 2015;16(3):923-6.
Tavares-Murta BM, Mendonca MA, Duarte NL, et al. Systemic leukocyte alterations are associated with inva- sive uterine cervical cancer. Int J Gynecol Cancer 2010; 20:1154-9.
Wang D, Yang JX, Cao DY, et al. Preoperative neutrophil- lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometriod adenocarcinoma. Onco Targets and Therapy 2013;6:211-6.
Gunaldi M, Goksu S, Erdem D, et al. Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study. Int J Clin Exp Med 2015;8(4):5937-42.
Kwon HC, Kim SH, Oh SY, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lym- phocyte ratio in patients with operable colorectal cancer. Biomarkers 2012;17(3):216-22.
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in col- orectal cancer. J Surg Oncol 2005;91(3):181-4.
Halazun KJ, Hardy MA, Rana AA et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009;250(1):141-51.
Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independant predic- tors of prognosis in resected pancreatic ductal adenocarci- noma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 2010;200(2):197-203.
Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non- small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137(2):425-8.
Wei Y, Jiang YZ, Qian WH. Prognostic role of NLR in uri- nary cancers: a meta-analysis. PloS One 2014;9(3): e92079.doi:10.1371/journal.pone.0092079
Cho HB, Hur HW, Kim SW, et al. Pre-treatment neu- trophil to lymphocyte ratio is elevated in epithelial ovar- ian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009;58(1):15-23.
Lee YY, Choi CH, Kim HJ, et al. Pretreatment Neutrophil: lymphocyte ratio as a prognostic factor in cervical carci- noma. Anticancer Res 2012;32(4):1555-62.
Zhang Y, Wang L, Liu Y, et al. Preoperative neutrophil- lymphocyte ratio before platelet/lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. Int J Gynecol Cancer 2014; 24(7):1319-25.
Mizunuma M, Yokoyama Y, Futagami M, Aoki M, Takai Y, Mizunuma H. The pretreatment neutrophil-to-lympho- cyte ratio predicts therapeutic response to radiation ther- apy and concurrent chemoradiation therapy in uterine cer- vical cancer. Int J Clin Oncol 2015; 20(5):989-96.
Massad LS, Einstein MH, Huh WK, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17:1-27.
Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
Balkwill F, Mantovoni A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neu- trophils, form important compartments for circulating vas- cular endothelial growth factor. Angiogenesis 2003; 6(4):283-7.
Klinger MH, Jelkmann W. Role of blood platelets in in- fection and inflammation. J Interferon Cytokine Res 2002; 22:913-22.
Smith RA, Bosonnet L, Ghaneh P, et al. The platelet-lym- phocyte ratio improves the predictive value of serum Ca 19-9 levels in determining patient selection for staging la- paroscopy in suspected periampullary cancer. Surgery 2008;143:658-66.
Patton AL, Duncan L, Bloom L, Phaneuf G, Zafar N. Atypical squamous cells, cannot exclude a high-grade in- traepithelial lesion and its clinical significance in post- menopausal, pregnant, postpartum, and contraceptive-use patients.